Exclusive

Publication

Byline

Location

Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4167586 in Participants with Obesity or Overweight who are Otherwise Healthy.

Singapore, Aug. 17 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate t... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012)

Singapore, Aug. 17 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy ... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012)

Singapore, Aug. 17 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy ... Read More


Singapore Clinical Trial: A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, multi-center study, with a primary efficacy endpoint at 12 weeks, to determine the efficacy, safety, and tolerability of fixed doses of 15 mg bid and 30 mg bid of evenamide as add-on in patients with documented treatment-resistant schizophrenia, which is not adequately controlled by a stable therapeutic dose of the patient’s current antipsychotic medication(s).

Singapore, Aug. 17 -- The Health Sciences Authority received information related to the study titled 'A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, m... Read More


Clinical Trial: An observational Study for Patent Hemostasis (China)

China, Aug. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'An observational Study for Patent Hemostasis'. The following are the other relevant det... Read More


Clinical Trial: Assesiing the Minimum Carbohydrate Requirement in Healthy Middle-Aged Chinese Adults via Dynamic β-Hydroxybutyrate Monitoring (China)

China, Aug. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Assesiing the Minimum Carbohydrate Requirement in Healthy Middle-Aged Chinese Adults vi... Read More


Clinical Trial: Evaluation of a Preservative-Free Cross-Linked Hyaluronic Acid and Aloe Vera Ophthalmic Solution for Post-Cataract Surgery Dry Eyes: A Prospective, Single-Arm, Interventional Study (China)

China, Aug. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Evaluation of a Preservative-Free Cross-Linked Hyaluronic Acid and Aloe Vera Ophthalmic... Read More


Clinical Trial: Research on the Application of Point-of-Care Ultrasound (POCUS)-Guided Fluid Management in Preventing and Treating Bronchopulmonary Dysplasia in Preterm Infants (China)

China, Aug. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Research on the Application of Point-of-Care Ultrasound (POCUS)-Guided Fluid Management... Read More


Clinical Trial: HAVEN-AI: A Prospective Clinical Validation Study of a Privacy-Preserving Locally Deployed Medical Imaging Artificial Intelligence Appliance in Secure Hospital Edge Networks (China)

China, Aug. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'HAVEN-AI: A Prospective Clinical Validation Study of a Privacy-Preserving Locally Deplo... Read More


Clinical Trial: A Study on the Establishment of an Integrated Nursing Model for Interventional Thrombolysis in Central Retinal Artery Occlusion (China)

China, Aug. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study on the Establishment of an Integrated Nursing Model for Interventional Thrombol... Read More